test

Jack Trottier

@Birchview Capital, Lp

Latest period2024 - Q3ReportedManaged Assets$115.222MTotal holdings61
Assets growth rate6.73%Assets growth rate (2-Q avg)-2.56%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Birchview Capital, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 61 positions.

Assets under management

The assets under management (AUM) of Birchview Capital, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 115.222M in assets, with a quarterly growth rate of 6.73% and a 2-quarter average growth rate of -2.56%. The portfolio is managed by Jack Trottier, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
ALKSAlkermes Plc
Recent Activity
1.22%
$1.399M
50,000 shares@ $27.99 avg price
EQTEqt Corporation
Recent Activity
New Position
1.11%
$1.268M
34,619 shares@ $36.64 avg price
ATECAlphatec Holdings Inc
Recent Activity
Increased 125%
0.96%
$1.101M
198,000 shares@ $5.56 avg price
KALVKalvista Pharmaceuticals Inc
Recent Activity
Increased 78.27%
0.83%
$949,560
82,000 shares@ $11.58 avg price
KNSAKiniksa Pharmaceuticals Ltd
Recent Activity
0.66%
$749,700
30,000 shares@ $24.99 avg price
TXG10x Genomics Inc
Recent Activity
0.59%
$677,400
30,000 shares@ $22.58 avg price
HALOHalozyme Therapeutics Inc
Recent Activity
0.5%
$572,400
10,000 shares@ $57.24 avg price
AXDXAccelerate Diagnostics Inc
Recent Activity
0.49%
$556,158
325,239 shares@ $1.71 avg price
CYTKCytokinetics Inc
Recent Activity
0.46%
$528,000
10,000 shares@ $52.8 avg price
INBXInhibrx Biosciences Inc
Recent Activity
Increased 165.16%
0.44%
$502,843
32,110 shares@ $15.67 avg price